Trinity Biotech plc to Announce First Quarter Fiscal Year 2018 Financial Results

NEXT STORY
Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited
PREV STORY
Hemispherx Announces Pricing of $2.57 Million Registered Direct Offering at a Premium to Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Anthrax Treatment: Worldwide Market Analysis & Outlook (2019-2023) by Product, Type and Geography with Key Player Profiling

Dublin, Dec. 13, 2018 (GLOBE NEWSWIRE) -- The "Global Anthrax Treatment Market 2019-2023" report ...

author_avatar
NASDAQ Market News

Medivir announces that Janssen decided to start a phase IIb study of combinations of Simeprevir, Odalasvir and AL-335 for the treatment of hepatitis C

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that Janssen Research & ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT BIOTECH’S FINANCIAL CALENDAR IN 2018

FIT Biotech OyCompany release December 18, 2017 at 4 pm EET                                  FIT BIOTECH'S FINANCIAL ...

author_avatar
NASDAQ Market News